Congruence Therapeutics
Develops small molecule correctors for diseases of protein misfolding
$39.5MSeries B
Role not disclosedDC
Driehaus Capital Management
Activity from announced rounds
Activity in this selectionvictor-riparbelli-f4aa0359
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $39.5M 1 disclosed · full round size, not this investor’s share